Merck (MRK) Reports Election of Dr. Stephen Mayo to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Dr. Stephen Mayo Elected to Merck Board of Directors
February 1, 2021 6:45 AM ESTKENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Stephen Steve L. Mayo, professor, California Institute of Technology, will join the companys Board of Directors effective March 15, 2021. Dr. Mayo will stand for election with the companys other directors at Mercks Annual Meeting of Shareholders on May 25, 2021. With the addition of Dr. Mayo, the Merck board will consist of 14 members.
We are pleased to welcome Dr. Mayo to the Merck Board. He brings extensive scientific expertise, and we look... More
